natgillin/translations-raw huggingface dataset:
Pregabalin Sandoz GmbH 25 mg hårde kapsler
Pregabalin Sandoz GmbH 25 mg hard capsules
Pregabalin Sandoz GmbH 25 mg hårde kapsler pregabalin
Pregabalin Sandoz GmbH 25 mg hard capsules pregabalin
Pregabalin Sandoz GmbH 300 mg hårde kapsler
Pregabalin Sandoz GmbH 300 mg hard capsules
Pregabalin Sandoz GmbH 300 mg hårde kapsler pregabalin
Pregabalin Sandoz GmbH 300 mg hard capsules pregabalin
Pregabalin Sandoz GmbH 50 mg hårde kapsler
Pregabalin Sandoz GmbH 50 mg hard capsules
Pregabalin Sandoz GmbH 50 mg hårde kapsler pregabalin
Pregabalin Sandoz GmbH 50 mg hard capsules pregabalin
Pregabalin Sandoz GmbH 75 mg hårde kapsler
Pregabalin Sandoz GmbH 75 mg hard capsules
Pregabalin Sandoz GmbH 75 mg hårde kapsler pregabalin
Pregabalin Sandoz GmbH 75 mg hard capsules pregabalin
Pregabalin Sandoz GmbH bør ikke tages under graviditet eller hvis De ammer, medmindre Deres læge har givet Dem en anden besked.
Pregabalin Sandoz GmbH should not be taken during pregnancy or when breast-feeding, unless you are told otherwise by your doctor.
Pregabalin Sandoz GmbH er et "generisk lægemiddel".
Pregabalin Sandoz GmbH is a ‘generic medicine’.
Pregabalin Sandoz GmbH er forbundet med svimmelhed og søvnighed, som kan øge risikoen for faldulykker hos ældre patienter.
Pregabalin Sandoz GmbH has been associated with dizziness and somnolence, which could increase the occurrence of accidental injury (fall) in elderly patients.
Pregabalin Sandoz GmbH er indiceret til behandling af generaliseret angst (GAD) hos voksne.
Pregabalin Sandoz GmbH is indicated for the treatment of Generalised Anxiety Disorder (GAD) in adults.
Pregabalin Sandoz GmbH kan forårsage sløret syn, synstab eller andre synsændringer, som kan være forbigående.
Pregabalin Sandoz GmbH may cause blurring or loss of vision, or other changes in eyesight, many of which are temporary.
Pregabalin Sandoz GmbH kan forårsage svimmelhed og søvnighed, og derfor kan det påvirke evnen til at køre bil eller betjene maskiner.
Pregabalin Sandoz GmbH may cause dizziness and somnolence and therefore may influence the ability to drive or use machines.
Pregabalin Sandoz GmbH kan påvirke evnen til at føre motorkøretøj og betjene maskiner i mindre eller moderat grad.
Pregabalin Sandoz GmbH may have minor or moderate influence on the ability to drive and use machines.
Pregabalin Sandoz GmbH kapsler kan tages både sammen med og uden mad.
Pregabalin Sandoz GmbH capsules may be taken with or without food.
Pregabalin Sandoz kan forårsage sløret syn, synstab eller andre synsændringer, som kan være forbigående.
Pregabalin Sandoz may cause blurring or loss of vision, or other changes in eyesight, many of which are temporary.
Pregabalin Sandoz kan forårsage svimmelhed og søvnighed, og derfor kan det påvirke evnen til at køre bil eller betjene maskiner.
Pregabalin Sandoz may cause dizziness and somnolence and therefore may influence the ability to drive or use machines.
Pregabalin Sandoz kan påvirke evnen til at føre motorkøretøj og betjene maskiner i mindre eller moderat grad.
Pregabalin Sandoz may have minor or moderate influence on the ability to drive and use machines.
Pregabalin Sandoz kapsler kan tages både sammen med og uden mad.
Pregabalin Sandoz capsules may be taken with or without food.
Pregabalin udskilles fra kroppen primært via renal udskillelse som uomdannet lægemiddelstof.
Pregabalin is eliminated from the systemic circulation primarily by renal excretion as unchanged drug.
Pregabalin udskilles i human mælk (se pkt.
Pregabalin is excreted into human milk (see section 5.2).
Pregabalin udskilles i human mælk (se pkt.
Pregabalin is excreted into human milk.
Pregabalin Zentiva 100 mg hårde kapsler er pakket i PVC/alu blistre som primær pakningsmateriale.
Pregabalin Zentiva 100 mg hard capsules are packed into PVC/alu blisters as primary packaging.
Pregabalin Zentiva 100 mg hårde kapsler Pregabalin
Pregabalin Zentiva 100 mg hard capsules Pregabalin
Pregabalin Zentiva 100 mg, 200 mg findes i pakninger af 21, 84 og 100 hårde kapsler.
Pregabalin Zentiva 100 mg, 200 mg is available in pack of 21, 84 and 100 hard capsules.
Pregabalin Zentiva 150 mg hårde kapsler er pakket i PVC/alu blistre som primær pakningsmateriale.
Pregabalin Zentiva 150 mg hard capsules are packed into PVC/alu blisters as primary packaging.
Pregabalin Zentiva 150 mg hårde kapsler Pregabalin
Pregabalin Zentiva 150 mg hard capsules Pregabalin
Pregabalin Zentiva 200 mg hårde kapsler er pakket i PVC/alu blistre som primær pakningsmateriale.
Pregabalin Zentiva 200 mg hard capsules are packed into PVC/alu blisters as primary packaging.
Pregabalin Zentiva 200 mg hårde kapsler Pregabalin
Pregabalin Zentiva 200 mg hard capsules Pregabalin
Pregabalin Zentiva 225 mg hårde kapsler er pakket i PVC/alu blistre som primær pakningsmateriale.
Pregabalin Zentiva 225 mg hard capsules are packed into PVC/alu blisters as primary packaging.
Pregabalin Zentiva 225 mg hårde kapsler Pregabalin
Pregabalin Zentiva 225 mg hard capsules Pregabalin
Pregabalin Zentiva 25 mg hårde kapsler er pakket i alu/alu (OPA/alu/PVC/alu)blistre som primær pakningsmateriale.
Pregabalin Zentiva 25 mg hard capsules are packed into alu/alu (OPA/alu/PVC/alu) blisters as primary packaging.
Pregabalin Zentiva 25 mg hårde kapsler Pregabalin
Pregabalin Zentiva 25 mg hard capsules Pregabalin
Pregabalin Zentiva 25 mg og 50 mg findes i pakninger af 14, 21, 56, 84 og 100 hårde kapsler.
Pregabalin Zentiva 25 mg and 50 mg is available in pack of 14, 21, 56, 84 and 100 hard capsules.
Pregabalin Zentiva 300 mg hårde kapsler er pakket i PVC/alu blistre som primær pakningsmateriale.
Pregabalin Zentiva 300 mg hard capsules are packed into PVC/alu blisters as primary packaging.
Pregabalin Zentiva 300 mg hårde kapsler Pregabalin
Pregabalin Zentiva 300 mg hard capsules Pregabalin
Pregabalin Zentiva 50 mg hårde kapsler er pakket i PVC/alu blistre som primær pakningsmateriale.
Pregabalin Zentiva 50 mg hard capsules are packed into PVC/alu blisters as primary packaging.
Pregabalin Zentiva 50 mg hårde kapsler Pregabalin
Pregabalin Zentiva 50 mg hard capsules Pregabalin
Pregabalin Zentiva 75 mg hårde kapsler er pakket i PVC/alu blistre som primær pakningsmateriale.
Pregabalin Zentiva 75 mg hard capsules are packed into PVC/alu blisters as primary packaging.
Pregabalin Zentiva 75 mg hårde kapsler Pregabalin
Pregabalin Zentiva 75 mg hard capsules Pregabalin
Pregabalin Zentiva 75 mg, 150 mg, 225 mg og 300 mg findes i pakninger af 14, 56 og 100 hårde kapsler.
Pregabalin Zentiva 75 mg, 150 mg, 225 mg and 300 mg is available in pack of 14, 56 and 100 hard capsules.
Pregabalin Zentiva er et "generisk lægemiddel".
Pregabalin Zentiva is a ‘generic medicine’.
Pregabalin Zentiva er forbundet med svimmelhed og søvnighed, som kan øge risikoen for faldulykker hos ældre patienter.
Pregabalin has been associated with dizziness and somnolence, which could increase the occurrence of accidental injury (fall) in elderly patients.
Pregabalin Zentiva er indiceret som supplerende behandling til voksne med partielle anfald med eller uden sekundær generalisering.
Pregabalin Zentiva is indicated as adjunctive therapy in adults with partial seizures with or without secondary generalisation.
Pregabalin Zentiva er indiceret til behandling af generaliseret angst (GAD) hos voksne.
Pregabalin Zentiva is indicated for the treatment of generalised anxiety disorder (GAD) in adults.
Pregabalin Zentiva indeholder lactosemonohydrat
Pregabalin Zentiva contains lactose monohydrate
Pregabalin Zentiva kan forårsage sløret syn, synstab eller andre synsændringer, som kan være forbigående.
Pregabalin may cause blurring or loss of vision, or other changes in eyesight, many of which are temporary.
Pregabalin Zentiva kan give svimmelhed, søvnighed og nedsat koncentrationsevne.
Pregabalin may produce dizziness, sleepiness and decreased concentration.
Pregabalin-clearance falder ofte med øget alder, svarende til det fald i kreatininclearance, som skyldes øget alder.
This decrease in pregabalin oral clearance is consistent with decreases in creatinine clearance associated with increasing age.
Pregabalins farmakokinetik blev evalueret hos pædiatriske patienter med epilepsi (aldersgrupper: 1- 23 måneder, 2-6 år, 7-11 år og 12-16 år) ved dosisniveauer på 2,5, 5, 10 og 15 mg/kg dagligt i et farmakokinetik- og tolerabilitetsstudie.
Pregabalin pharmacokinetics were evaluated in paediatric patients with epilepsy (age groups: 1 to 23 months, 2 to 6 years, 7 to 11 years and 12 to 16 years) at dose levels of 2.5, 5, 10 and 15 mg/kg/day in a pharmacokinetic and tolerability study.
Pregabalins sikkerhed og virkning hos børn under 12 år og unge (12-17 år) er ikke klarlagt.
The safety and efficacy of pregabalin in children below the age of 12 years and in adolescents (12 – 17 years of age) have not been established.
Pregabalins sikkerhed og virkning hos børn under 12 år og unge (12-17 år) er ikke klarlagt.
The safety and efficacy of pregabalin in children below the age of 12 years and in adolescents (12- 17 years of age) have not been established.
Pregabalins steady-state farmakokinetik er ens hos raske forsøgspersoner, hos patienter med epilepsi i anti-epileptisk behandling og hos patienter med kroniske smerter.
Pregabalin steady-state pharmacokinetics are similar in healthy volunteers, patients with epilepsy receiving anti-epileptic drugs and patients with chronic pain..
Pregelatineret majsstivelse,
Pre-gelatinised maize starch
Pregunte a su farmacéutico cómo deshacerse de los envases y de los medicamentos que ya no necesita.
Ask your pharmacist how to throw away medicines you no longer use.
Premix til foderlægemiddel.
Premix for medicated feeding stuff
Premix til medicineret foderstof
Premix for medicated feeding stuff
Premix til medicineret foderstof
Premix for medicated feedingstuff
Preotact 100 mikrogram pulver og solvens til injektionsvæske, opløsning i en fyldt pen
Preotact 100 micrograms powder and solvent for solution for injection in a pre-filled pen
Preotact 100 mikrogram pulver og solvens til injektionsvæske, opløsning i fyldt pen.
Preotact 100 micrograms powder and solvent for solution for injection in a pre-filled pen Parathyroid hormone
Preotact 100 mikrogram pulver og solvens til injektionsvæske, opløsning Parathyreoideahormon
Preotact 100 micrograms powder and solvent for solution for injection Parathyroid hormone
Preotact 100 mikrogram pulver og solvens til injektionsvæske, opløsning, i fyldt pen.
Preotact 100 micrograms powder and solvent for solution for injection in a pre-filled pen.
Preotact er blevet administreret som enkeltdosis op til 5 mikrogram/kg og som gentagne doser op til 3 mikrogram/kg/dag i 3 dage og op til 2,5 mikrogram/kg/dag i 7 dage.
Preotact has been administered in single doses up to 5 micrograms/kg and in repeated doses of up to 3 microgramskgday for 3 days and up to 2.5 microgramskgday for 7 days.
Preotact fås i pakker med 2 fyldte penne.
Preotact is available in a pack with 2 pre-filled pens.
Preotact fås i pakninger med 2 fyldte penne.
Preotact is available in packs of 2 pre-filled pens.
Preotact injiceres ved hjælp af en fyldt injektionspen.
Preotact is injected using a pre-filled pen.
Preotact kan anvendes i op til 24 måneder, hvorefter patienterne kan behandles med et bisphosphonat (et lægemiddel, som mindsker tabet af knoglemasse).
Preotact can be used for up to 24 months, after which patients can be treated with a bisphosphonate (a medicine that reduces bone loss).
PrEP-huskekort
PrEP reminder card
PrEP-tjekliste til ordinerende læger
PrEP Checklist for prescribers
PrEP-undervisningsbrochure for personer i risikogruppe med titlen ”Vigtige oplysninger om Truvada for at reducere risikoen for at få infektion forårsaget af humant immundefektvirus (HIV-infektion)”
PrEP educational brochure for the individual at risk entitled ‘Important Information About Truvada to Reduce the Risk of getting Human Immunodeficiency Virus (HIV) Infection’
PrEP-undervisningsbrochure til ordinerende læger med titlen ”Vigtige sikkerhedsoplysninger til ordinerende læger om Truvada ved indikationen Profylakse før eksponering (PrEP)”
PrEP educational brochure for prescribers entitled ‘Important Safety Information for Prescribers About Truvada for a Pre-exposure Prophylaxis (PrEP) Indication’
Prepandemic Influenza vaccine (H5N1) (surface antigen, inactivated, adjuvanted) Novartis Vaccines and Diagnostics er en "præpandemisk" vaccine.
Prepandemic influenza vaccine (H5N1) (surface antigen, inactivated, adjuvanted) Novartis Vaccines and Diagnostics is a ‘prepandemic’ vaccine.
Prepandemic Influenza vaccine (H5N1) (surface antigen, inactivated, adjuvanted) Novartis Vaccines and Diagnostics er en injektionsvæske, suspension i fyldt injektionssprøjte.
Prepandemic Influenza vaccine (H5N1) (surface antigen, inactivated, adjuvanted) Novartis Vaccines and Diagnostics is a suspension for injection in a pre-filled syringe.
Prepandemic Influenza vaccine (H5N1) (surface antigen, inactivated, adjuvanted) Novartis Vaccines and Diagnostics injektionsvæske
Prepandemic Influenza vaccine (H5N1) H5N1 influenza vaccine
Prepandemic Influenza vaccine (H5N1) (surface antigen, inactivated, adjuvanted) Novartis Vaccines and Diagnostics injektionsvæske, suspension i fyldt injektionssprøjte
Prepandemic Influenza vaccine (H5N1) (surface antigen, inactivated, adjuvanted) Novartis Vaccines and Diagnostics suspension for injection in pre-filled syringe Prepandemic Influenza vaccine (H5N1) (surface antigen, inactivated, adjuvanted)
Prepandemic Influenza vaccine (H5N1) (surface antigen, inactivated, adjuvanted) Novartis Vaccines and Diagnostics injektionsvæske, suspension i fyldt injektionssprøjte.
Prepandemic Influenza vaccine (H5N1) (surface antigen, inactivated, adjuvanted) Novartis Vaccines and Diagnostics suspension for injection in pre-filled syringe.
Prepandemic Influenza vaccine (H5N1) (surface antigen, inactivated, adjuvanted) Novartis Vaccines and Diagnostics præpandemisk influenzavaccine (H5N1) (overfladeantigen, inaktiveret, adjuveret)
Prepandemic influenza vaccine (H5N1) (surface antigen, inactivated, adjuvanted) Novartis Vaccines and Diagnostics prepandemic influenza vaccine (H5N1) (surface antigen, inactivated, adjuvanted)
Prepandemic Influenza vaccine (H5N1) (surface antigen, inactivated, adjuvanted) Novartis Vaccines and Diagnostics, indeholdende HA fra A/Vietnam/1194/2004 (homolog med challenge-stammen), og en Prepandemic Influenza vaccine (H5N1) (surface antigen, inactivated, adjuvanted) Novartis Vaccines and Diagnostics- lignende H5N1 vaccine, indeholdende hæmagglutinin fra A/turkey/Turkey/1/2005-lignende (heterolog med challenge-stammen) blev testet.
Prepandemic Influenza vaccine (H5N1) (surface antigen, inactivated, adjuvanted) Novartis Vaccines and Diagnostics containing HA from A/Vietnam/1194/2004 (homologous to the challenge strain) and an Prepandemic Influenza vaccine (H5N1) (surface antigen, inactivated, adjuvanted) Novartis Vaccines and Diagnostics -like H5N1 vaccine, containing hemagglutinin from the A/turkey/Turkey/1/2005-like (heterologous to the challenge strain) were tested.
Prepandemisk influenzavaccine (H5N1)
Prepandemic influenza vaccine (H5N1)
Prepandemisk influenzavaccine (H5N1) (split virion, inaktiveret, adjuveret) GlaxoSmithKline Biologicals 3,75 mikrogram suspension og emulsion til injektionsvæske, emulsion.
Prepandemic influenza vaccine (H5N1) (split virion, inactivated, adjuvanted) GlaxoSmithKline Biologicals 3.75 µg suspension and emulsion for emulsion for injection
Prepandemisk influenzavaccine (H5N1) (split virion, inaktiveret, adjuveret) GlaxoSmithKline Biologicals 3,75 mikrogram suspension til injektionsvæske, emulsion.
Prepandemic influenza vaccine (H5N1) (split virion, inactivated, adjuvanted) GlaxoSmithKline Biologicals 3.75 µg suspension for emulsion for injection
Prepandrix består af to hætteglas: Suspension: flerdosishætteglas med antigen Emulsion: flerdosishætteglas med adjuvans.
Prepandrix consists of two containers: Suspension: multidose vial containing the antigen, Emulsion: multidose vial containing the adjuvant.
Prepandrix er en vaccine, som anvendes til voksne i alderen fra 18.
Prepandrix is a vaccine for use in adults from 18 years old.
Prepandrix indeholder influenzastammen ”A/Indonesia/05/2005” (H5N1).
Prepandrix contains a flu strain called ‘A/Indonesia/05/2005’ (H5N1).
Prepandrix suspension og emulsion til injektionsvæske, emulsion
Prepandrix suspension and emulsion for emulsion for injection
Prepandrix suspension og emulsion til injektionsvæske, emulsion.
Prepandrix suspension and emulsion for emulsion for injection
Prepandrix suspension og emulsion til injektionsvæske, emulsion.
Prepandrix suspension and emulsion for emulsion for injection.
Prepandrix’ sikkerhed og virkning hos børn i alderen under 3 år og hos børn og teenagere i alderen 10- 17 år er ikke klarlagt.
The safety and efficacy of Prepandrix in children aged less than 3 years and in children and adolescents aged 10 to 17 years have not been established.
Prequenza Te
Prequenza Prequenza Prequenza Te Te
Prequenza Te 16
Prequenza Prequenza Prequenza Te Te
PRES blev ikke rapporteret i det pivotale fase III-studie med mCRC-patienter.
PRES was not reported in the pivotal Phase III study of MCRC patients.
PRES blev ikke rapporteret ved det pivotale fase III-studie med mCRC-patienter.
PRES was not reported in the pivotal phase III study of MCRC patients.
Pres blisterbeholderen helt ned.
Push the blister tray down fully.
PRES bør tages i betragtning hos patienter, der indfinder sig med krampeanfald, hovedpine, synsforstyrrelser, konfusion eller ændret mental status.
PRES should be considered in any patient presenting with seizures, headache, visual disturbances, confusion or altered mental function.
Pres de to kammerudløsningsknapper på siden af hoveddelen ind samtidigt.
Squeeze the two chamber release buttons at the same time on the side of the base.
Pres den fyldte pen fast mod huden (se figur 5 og 6)
Push the pre-filled pen firmly against the skin (see figures 5 and 6)
Pres den grå knap ind og tag insulinblisteren ud.
Press the grey button and pull out the insulin blister.
Pres den hvide plastikhætte på hætteglasset op, så hætteglassets prop kommer til syne.
Pop off the white plastic cap from the vial to see the top of the vial stopper.
Pres den hvide stempelstang ned for at injicere den flydende medicin indtil sprøjten er tom.
Push the white plunger rod to inject the liquid medication until the syringe is empty.
Pres den åbne ende af den fyldte pen fast mod huden i en ret vinkel (90 grader), indtil sikkerhedskraven glider helt ind i clear cover (figur 6).
Push the open end of the pre-filled pen firmly against the skin at a 90-degree angle until the Safety Sleeve slides fully into the Clear Cover (Figure 6).
Pres derefter fingerpladen nær sprøjtens spids ned ved at bruge tommel og pegefinger (C) indtil fingerpladen møder den øverste kant af rekonstitutionslåget (Bio-Set).
Then, strongly press down the fingerplate near the syringe tip using your thumb and index finger (C) until the finger plate meets the top edge of the reconstitution cap (Bio-Set).
Pres en steril gazeserviet mod injektionsstedet i nogle sekunder.
Apply pressure to the injection site for a few seconds using a sterile gauze pad.
PRES er et syndrom med subkortikalt vasogent ødem, der diagnosticeres ved MR-skanning af hjernen, og som er blevet observeret sjældent i forbindelse med vandetanibbehandling i kombination med kemoterapi.
PRES is a syndrome of subcortical vasogenic oedema diagnosed by a MRI of the brain, has been observed infrequently with vandetanib treatment in combination with chemotherapy.
PRES er et syndrom med subkortikalt vasogent ødem, der diagnosticeres ved MR-skanning af hjernen, og som er blevetobserveret sjældent i forbindelse med vandetanibbehandling kombination med kemoterapi.
PRES is a syndrome of subcortical vasogenic oedema diagnosed by a MRI of the brain, has been observed infrequently with vandetanib treatment in combination with chemotherapy.
PRES er også blevetobserveret hos patienter, der fik vandetanib som monoterapi.
PRES has also been observed in patients receiving vandetanib as monotherapy.
Pres et stykke gazebind over injektionsstedet i 10 sekunder.
Using a piece of gauze, apply pressure over the injection site for 10 seconds.
Pres et stykke sterilt vat eller gaze over injektionsstedet i et par sekunder.
Place a sterile cotton ball or gauze over the injection site and press for several seconds.
Pres et stykke vat over injektionsstedet i 10 sekunder.
Press a cotton ball over the injection site for 10 seconds.
Pres eventuelle bobler til spidsen af sprøjten
Move any bubbles to the tip of the syringe
Pres filterkanylen ned i midten af hætteglassets gummiprop indtil nålen når hætteglassets bund.
Push the filter needle into the centre of the vial stopper until the needle touches the bottom edge of the vial.
Pres filterkanylen ned i midten af hætteglassets gummiprop, indtil kanylen når hætteglassets bund.
Push the blunt filter needle into the centre of the vial stopper until the needle touches the bottom edge of the vial.
Pres filterkanylen ned i midten af hætteglassets gummiprop, indtil kanylen når hætteglassets bund.
Push the filter needle into the centre of the vial stopper until the needle touches the bottom edge of the vial.
Pres filterkanylen ned midt i hætteglassets gummiprop, indtil kanylen er stukket helt ned i hætteglasset og spidsen berører bunden af hætteglasset.
Push the filter needle into the centre of the vial stopper until the needle is completely inserted into the vial and the tip touches the bottom or bottom edge of the vial.
Pres forsigtigt i 1 til 2 minutter.
Press gently for 1 to 2 minutes.
Pres forsigtigt sprøjtens stempel med en fast hånd, indtil al væsken er injiceret ind under huden, og der ikke er mere væske tilbage i sprøjten.
Slowly push the plunger of the syringe with a steady hand until all the fluid is injected into the skin and no liquid remains in the syringe.
Pres forsigtigt stemplet ned så langt, som det vil.
Gently press in the plunger as far as it will go.
Pres forsigtigt stemplet ned til 1,0 ml mærket er på linje med den øverste del af stemplet.
Carefully pull the plunger down until the 1.0 ml mark is in line with the upper end of the plunger.
Pres forsigtigt stemplet op.
Carefully push the plunger up.
Pres hele kanylen lige ned i huden i en ret vinkel.
Put the whole needle straight into the skin fold at a right angle.
pres herefter den farvede beskyttelseshætte ned mod en flad overflade, indtil den dækker nålen. du vil kunne høre et klik.
then gently press the coloured needle protector down on a flat surface until it covers the needle. you will hear a click.
Pres ikke denne ind, den skal nemt kunne sættes på plads, (hvis den nye insulinfrigivelsesenhed ikke kan sættes på plads eller sidder stramt, fjern da denne og prøv igen).
Do not force, it should easily drop into place. (If the new IRU does not drop into place or fits tightly, remove and try again).
Pres ikke resoribletten ud af blisterpakningen.
Do not push the tablet through the blister.
Pres ikke.
Don’t squeeze it.
Pres kanylen gennem midten af proppen på hætteglasset som vist.
Push the needle through the centre of vial stopper, as shown.
Pres kanylen helt ind i huden med en hurtig, kort bevægelse i en vinkel mellem 45 og 90 (se billede 10).
With a quick, short motion, push the needle all the way into the skin at an angle between 45° and 90° (see Diagram 10).
Pres kanylen helt ind i huden med en hurtig, kort bevægelse i en vinkel mellem 45 og 90 (se billede 10).
With a quick, short motion, push the needle all the way into the skin at an angle between 45° and 90° (see Diagram10).
Pres kanylen helt ind i huden med en hurtig, kort bevægelse i en vinkel mellem 45 og 90 (se billede 13).
With a quick, short motion, push the needle all the way into the skin at an angle between 45° and 90° (see Diagram 13).
Pres kanylen helt ind i huden med en hurtig, kort bevægelse i en vinkel mellem 45 og 90 (se billede 18).
With a quick, short motion, push the needle all the way into the skin at an angle between 45° and 90° (see Diagram 18).
Pres kanylen helt ind i huden med en hurtig, kort bevægelse i en vinkel mellem 45 og 90 (se billede 3).
With a quick, short motion, push the needle all the way into the skin at an angle between 45° and 90° (see Diagram 3).